-W V Good Researcher Activity Profile

Research Author Detailed Information 

W V Good Publication Rate By Year

W V Good has published 1 paper(s) in 1993, 1 paper(s) in 2001, 1 paper(s) in 2002, 1 paper(s) in 2004, 1 paper(s) in 2006, 8 paper(s) in 2007, 3 paper(s) in 2008, for a total of 16 research publications in total.

W V Wv Good Author Information

LAST NAME: good

FIRST NAME: W V

INITIALS: wv

AFFILIATION:

Papers

W V Good's Publication Record

1. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy. Year Published: 2001
Department of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology and Oncology, The Children's Hospital Research Foundation, Cincinnati, Ohio 45229, USA. rlgendron@chmcc.org
2. Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro. Year Published: 2002
Division of Basic Medical Sciences, Department of Medicine, Memorial University of Newfoundland, St. John's NF, A1B 3V6, Canada.
3. Conditional knockdown of tubedown-1 in endothelial cells leads to neovascular retinopathy. Year Published: 2004
Division of Basic Medical Sciences, Department of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
4. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity. Year Published: 2006
Division of Basic Medical Sciences, Department of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada. rgendron@mun.ca
5. Validation study of VEP vernier acuity in normal-vision and amblyopic adults. Year Published: 2007
Smith-Kettlewell Eye Research Institute, San Francisco, California 94115, USA. chuanhou@ski.org
6. The spectrum of vision impairment caused by pediatric neurological injury. Year Published: 2007
7. Technology and retinopathy of prematurity diagnosis: the new frontier. Year Published: 2007
8. Genomics and proteomics of retinopathy of prematurity: DNA-based prevention and treatment. Year Published: 2007
9. Technology and retinopathy of prematurity diagnosis: the new frontier. Year Published: 2007
10. Genomics and proteomics of retinopathy of prematurity: DNA-based prevention and treatment. Year Published: 2007
11. The spectrum of vision impairment caused by pediatric neurological injury. Year Published: 2007
12. The spectrum of vision impairment caused by pediatric neurological injury. Year Published: 2007
13. Standardization of retinopathy of prematurity clinical examinations in clinical trials: risks, benefits and alternatives. Year Published: 2008
The Smith-Kettlewell Eye Research Institute, San Francisco, California, USA.
14. Mitochondrial disorders: analysis of their clinical and imaging characteristics. Year Published: 1993
Department of Radiology, University of California San Francisco 94143-0628.
15. Standardization of retinopathy of prematurity clinical examinations in clinical trials: risks, benefits and alternatives. Year Published: 2008
16. Retinopathy of prematurity: postmenstrual age at threshold in a transitional economy is similar to that in developed countries. Year Published: 2008
Department of Ophthalmology, Royal Children's Hospital, Melbourne, Victoria, Australia. smcarden@aol.com